Close Menu

NEW YORK – Chinese infectious disease startup Vision Medicals has raised $14 million in a Series A financing round.

The round, which closed last week, was led by Volcanics Venture and CASH Capital.

The company, founded in May 2018 and headquartered in Guangzhou in southern China, has developed a CRISPR-based rapid diagnostics platform for pathogen detection and a metagenomics/metatranscriptomics platform.

It also has a proprietary pathogen nucleic acid enrichment technology (Patho-NET) and microbial databases.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Department of Justice has proposed a rule change to enable DNA to be collected from migrants, the Associated Press reports.

Bernard Fisher, a surgeon who changed how breast cancer is treated, has died at 101, the New York Times reports.

Washington Post columnist writes that she is skeptical about DNA-based diets.

In PNAS this week: recurrent inactivation of DEPDC5 in gastrointestinal stromal tumors, taxonomic reliability of GenBank sequences, and more.